YESCARTA (Kite Pharma, Inc.)


Welcome to the PulseAid listing for the YESCARTA drug offered from Kite Pharma, Inc.. This pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.

LABELER NAME / MANUFACTURER: Kite Pharma, Inc.
NON-PROPRIETARY NAME: axicabtagene ciloleucel
SUBSTANCE NAME: AXICABTAGENE CILOLEUCEL
TYPE: CELLULAR THERAPY
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-10-18
END MARKETING DATE: 0000-00-00


YESCARTA CELLULAR THERAPY Details:

Item DescriptionYESCARTA from Kite Pharma, Inc.
LABELER NAME: Kite Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2000000(1/68mL)
START MARKETING DATE: 2017-10-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71287-119_51bfd1c5-cbb2-48a1-a390-472955fefe1a
PRODUCT NDC: 71287-119
APPLICATION NUMBER: BLA125643

Other AXICABTAGENE CILOLEUCEL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Kite Pharma, Inc.YESCARTA